Internal Medicine Alert – August 30, 2011
August 30, 2011
View Archives Issues
-
The Broken Heart: It CAN Be Mended
The authors advocate that cardiovascular magnetic resonance imaging using specific criteria may be useful as a diagnostic tool for patients with stress cardiomyopathy at the time of acute clinical presentation. -
Beware of the Single Blood Pressure
Single blood pressure (BP) measurements are not reflective of the average BP 20% of the time. A series of BPs should be averaged for medical decision making. A series of home BP recordings is more accurate than those in the office for assessing the control of BP among hypertensive patients. -
Something's Fishy — DHA and Prostate Cancer
In a shocking series of findings, this well-done prospective study showed that in men older than age 55 years a higher proportion of serum omega-3 fatty acids, specifically DHA, actually may increase the risk for high-grade prostate cancer. -
Ticagrelor Tablets (Brilinta™)
A third oral antiplatelet inhibitor has been approved by the FDA to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS). Ticagrelor is an adenosine diphosphate receptor P2Y12 inhibitor similar to clopidogrel and prasugrel. It is marketed by AstraZeneca as Brilinta. -
Clinical Briefs By Louis Kuritzky, MD
Since two-thirds of americans are overweight or obese, most of us should probably be trying to better understand why.